|Bid||100.53 x 1000|
|Ask||102.29 x 1200|
|Day's Range||100.56 - 102.30|
|52 Week Range||61.61 - 102.89|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||58.48|
|Earnings Date||Oct. 14, 2020 - Oct. 19, 2020|
|Forward Dividend & Yield||1.44 (1.42%)|
|Ex-Dividend Date||Jul. 14, 2020|
|1y Target Est||105.76|
Top Analyst Reports for Adobe, Abbott & Barrick Gold
Abbott Labs still in buy zone from 100.10 buy point.
Abbott Laboratories (NYSE: ABT) makes for a terrific investment for many reasons. For long-term investors, it starts with the Illinois-based company's rich history of dividend growth. Abbott is well on its way to becoming a Dividend King in a couple of years.The dividend currently yields about 1.4% annually, a bit short of the S&P 500 average of 2%.